MC2R MODULATOR COMPOUNDS

The disclosures herein relate to novel compounds of Formula (1); or a salt thereof, wherein A, Z, X, L1, L2, L3, RA, RB, RC, RD, Y1 and Y2 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with the melanocortin subtype-2...

Full description

Saved in:
Bibliographic Details
Main Authors SANDERSON, Adam Jan, SANZ, Laia Malet, BROWN, Giles Albert, TEHAN, Benjamin, MUSGAARD, Maria
Format Patent
LanguageEnglish
French
Published 29.08.2024
Subjects
Online AccessGet full text

Cover

Loading…